Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.

Shimizu M, Kuroda M, Sakashita N, Konishi M, Kaneda H, Igarashi N, Yamahana J, Taneichi H, Kanegane H, Ito M, Saito S, Ohta K, Taniguchi T, Furuichi K, Wada T, Nakagawa M, Yokoyama H, Yachie A.

Cytokine. 2012 Dec;60(3):694-700. doi: 10.1016/j.cyto.2012.07.038. Epub 2012 Aug 25.

PMID:
22929411
2.

Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.

Shiraishi M, Ichiyama T, Matsushige T, Iwaki T, Iyoda K, Fukuda K, Makata H, Matsubara T, Furukawa S.

J Neuroimmunol. 2008 May 30;196(1-2):147-52. doi: 10.1016/j.jneuroim.2008.02.012. Epub 2008 Apr 14.

PMID:
18410971
3.

Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.

Kuroda M, Shimizu M, Inoue N, Ikeno I, Nakagawa H, Yokoi A, Niida Y, Konishi M, Kaneda H, Igarashi N, Yamahana J, Taneichi H, Kanegane H, Ito M, Saito S, Furuichi K, Wada T, Nakagawa M, Yokoyama H, Yachie A.

Neurochem Int. 2015 Jun-Jul;85-86:24-30. doi: 10.1016/j.neuint.2015.04.003. Epub 2015 Apr 17.

PMID:
25895963
4.

Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.

Shimizu M, Kuroda M, Inoue N, Konishi M, Igarashi N, Taneichi H, Kanegane H, Ito M, Saito S, Yachie A.

Cytokine. 2014 Mar;66(1):1-6. doi: 10.1016/j.cyto.2013.12.005. Epub 2013 Dec 31.

PMID:
24548418
5.

Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111.

Matano S, Inamura K, Konishi M, Okumura T, Kawai H, Okamura T, Takata Y, Yamada K, Obata M, Nagata H, Muramoto Y, Sugimoto T.

J Infect Chemother. 2012 Aug;18(4):558-64. doi: 10.1007/s10156-011-0336-9. Epub 2011 Nov 15.

PMID:
22080202
6.

Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.

Piercefield EW, Bradley KK, Coffman RL, Mallonee SM.

Arch Intern Med. 2010 Oct 11;170(18):1656-63. doi: 10.1001/archinternmed.2010.346.

PMID:
20937925
7.

[Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].

Prado V, Cordero J, Garreaud C, Olguin H, Arellano C, Nachar CL, Misraji A, Martínez J, Tous M, Rivas M, et al.

Rev Med Chil. 1995 Jan;123(1):13-22. Spanish.

PMID:
7569441
9.

Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.

Zimmerhackl LB, Rosales A, Hofer J, Riedl M, Jungraithmayr T, Mellmann A, Bielaszewska M, Karch H.

Semin Thromb Hemost. 2010 Sep;36(6):586-93. doi: 10.1055/s-0030-1262880. Epub 2010 Sep 23.

PMID:
20865635
10.

Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Shimizu M, Inoue N, Kuroda M, Mizuta M, Sugimoto N, Kaneda H, Ohta K, Yachie A.

Clin Exp Nephrol. 2017 Feb;21(1):76-82. doi: 10.1007/s10157-016-1254-z. Epub 2016 Mar 5.

PMID:
26945868
11.
12.

Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.

Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG.

Pediatr Res. 2002 Dec;52(6):928-34.

PMID:
12438672
13.

Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome.

Proulx F, Turgeon JP, Litalien C, Mariscalco MM, Robitaille P, Seidman E.

Pediatr Infect Dis J. 1998 Oct;17(10):899-904.

PMID:
9802632
14.

Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues.

Westerholt S, Hartung T, Tollens M, Güstrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R.

Cytokine. 2000 Jun;12(6):822-7.

PMID:
10843773
15.

Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.

Westerholt S, Pieper AK, Griebel M, Volk HD, Hartung T, Oberhoffer R.

Clin Diagn Lab Immunol. 2003 Nov;10(6):1090-5.

16.

Plasma cytokine levels in hemolytic uremic syndrome.

van de Kar NC, Sauerwein RW, Demacker PN, Grau GE, van Hinsbergh VW, Monnens LA.

Nephron. 1995;71(3):309-13.

PMID:
8569980
17.

Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection.

Inward CD, Varagunam M, Adu D, Milford DV, Taylor CM.

Arch Dis Child. 1997 Aug;77(2):145-7.

18.

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.

Pediatrics. 2005 Jun;115(6):e673-80.

PMID:
15930195
19.

Epidemiological analysis of a large enterohaemorrhagic Escherichia coli O111 outbreak in Japan associated with haemolytic uraemic syndrome and acute encephalopathy.

Yahata Y, Misaki T, Ishida Y, Nagira M, Watahiki M, Isobe J, Terajima J, Iyoda S, Mitobe J, Ohnishi M, Sata T, Taniguchi K, Tada Y, Okabe N; E. coli O111 Outbreak Investigation Team.

Epidemiol Infect. 2015 Oct;143(13):2721-32. doi: 10.1017/S0950268814003641. Epub 2015 Jan 20.

PMID:
25600435
20.

Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients.

Kulkarni H, Goldwater PN, Martin A, Bettelheim KA.

Comp Immunol Microbiol Infect Dis. 2002 Jul;25(4):249-68.

PMID:
12135239

Supplemental Content

Support Center